Intensity Therapeutics Shareholders Engage and Elect at Annual Meeting

Intensity Therapeutics, Inc. (INTS) has provided an announcement.

Intensity Therapeutics, Inc. successfully conducted its Annual Meeting via live webcast on July 17, 2024, where a significant 62.15% of its shareholders participated. They approved the 2024 Employee Stock Purchase Plan, elected two Class I directors for a three-year term, and ratified the appointment of EisnerAmper LLP as the company’s independent auditor for the upcoming fiscal year. These decisions reflect shareholder confidence and active engagement in the company’s future direction.

Find detailed analytics on INTS stock on TipRanks’ Stock Analysis page.